Searchable abstracts of presentations at key conferences in endocrinology

ea0025pl3biog | Society for Endocrinology Transatlantic Medal Lecture | SFEBES2011

Society for Endocrinology Transatlantic Medal Lecture

Kopchick J J

J J Kopchick, Ohio University, Athens, Ohio, USA. AbstractDr John J Kopchick is an internationally recognized leader in the growth hormone (GH) field. Since 1987, he has held the Milton and Lawrence H Goll Eminent Scholar Professorship in Molecular and Cellular Biology and directs the Growth/Obesity/Diabetes Section of the Edison Biotechnology Institute at Ohio University in Athens, Ohio. He also is Professor in the B...

ea0026p489 | Thyroid cancer | ECE2011

Value of sonographic index point and resistivity index in the diagnosis of the malignant potential of nodular thyroid disease

Jain V , Toppo J N , Masih K , Jacob J J

Objective: To assess the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of sonographic index point and resistivity index in predicting the risk for malignancy in thyroid nodules.Methods: Fifty consecutive patients undergoing thyroid ultrasound for clinical nodular thyroid diseases prior to planned surgery were recruited for the study. Sonographic index point was calculated for each nodule using morphological...

ea0064018 | Osteoporosis Treatment Gap in the FRISBEE cohort | BES2019

Osteoporosis treatment gap in the FRISBEE cohort

Smeys C , Iconaru L , Kinnard V , Baleanu F , Moreau M , Bergmann P , Body J-J

Introduction: Osteoporosis is characterized by a low bone mass and a microarchiterctural disruption. Ageing and estrogen deficiency are the two most important factors for developing osteoporosis. With advanced age the balance between bone formation and resorption becomes progressively negative and non-bone factors contribute to the increased fracture risk with advancing age. Osteoporotic fractures constitute a major cause of morbidity and mortality in the elderly. Post-menopau...

ea0025p11 | Bone | SFEBES2011

Bone turnover markers in patients on aminobisphosphonate therapy for osteoporosis

Crowley R K , Brady J J , Kilbane M , McKenna M J

Aminobisphosphonates impair osteoclast cell function and reduce bone remodelling rate. It has been speculated that atypical femoral fractures in patients on bisphosphonates are the result of impaired bone remodelling.The primary aim of this prospective study was to assess levels of bone remodelling in patients with osteoporosis on aminobisphosphonate therapy by measurement of bone turnover markers. The secondary aim was to assess the adequacy of concomit...

ea0021p376 | Thyroid | SFEBES2009

A 10-year retrospective analysis of variable-dose radioactive iodine therapy for hyperthyroidism

Wahab R Abdul , Cullen M J , Nolan J J , Healy M L , McQuaid S E , O'Reilly G

Introduction and methods: Controversy exists regarding the optimal dosing regimen of radioactive iodine (RAI) for the treatment of hyperthyroidism. The dose of RAI was individualised, based on the size of the thyroid gland and 24-h RAI uptake. We performed a 10-year retrospective analysis of patients with hyperthyroidism treated with variable dose RAI, with a cure defined as eu- or hypothyroidism.Results: One hundred and forty-nine patients with hyperthy...

ea0026oc5.1 | Hormone metabolism and action | ECE2011

ESE Young Investigator Award

Hoekstra M , Vergeer M , Hildebrand R B , van der Sluis R J , Kastelein J J , Van Eck M , Kuivenhoven J A , Van Berkel T J C

Adrenal-derived glucocorticoids originate from their precursor cholesterol. Scavenger receptor BI (SR-BI) is a major high-density lipoprotein (HDL) receptor that mediates the selective uptake of cholesteryl esters (CE) from this lipoprotein in the circulation. In our present studies in SR-BI knockout (KO) mice and human carriers of a functional mutation in the extracellular domain of SR-BI (P297S), we determined whether SR-BI-mediated uptake of HDL-CE is required for adrenal g...

ea0073ep76 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Hepatogenous diabetes: is it real?

David Veríssimo , Ivo Catarina , Vitória Duarte , Silva Joao , Lopes Luis , Passos Dolores , J Jácome Castro , Marcelino Mafalda

IntroductionDiabetes mellitus (DM) due to cirrhosis is described as hepatogenous diabetes (HD). Despite being frequently described in the literature, it is not recognized as an entity by the ADA/EASD.Case reportWoman, 70 years old, previous history of autoimmune hepatitis with Child-Turcotte-Pugh A cirrhosis (CTP-A) since 2018, arterial hypertension and overweight (BMI 29.1 kg/m2). No personal or f...

ea0073ep86 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Bariatric surgery: a shift in metabolic control

David Veríssimo , Ivo Catarina , Vitória Duarte , Silva Joao , Lopes Luis , Passos Dolores , J Jácome Castro , Marcelino Mafalda

IntroductionObesity is a chronic disease that is associated with several comorbidities, decreased quality of life, and increased mortality rate. Bariatric surgery is the most effective therapy for obese patients with class III and class II with metabolic diseases. Its effectiveness is not only related to the weight reduction, but also to the improvement of the metabolic profile. The aim of this study is to characterize the effects of gastroplasty with Ro...

ea0040p12 | (1) | ESEBEC2016

Ectopic cushing syndrome by an aggressive gastroenteropancreatic neuroendocrine carcinoma

Lazaro C Robles , Portella L P Llamocca , Marcos A I Sanchez , Ruiz A Herrero , Alvarado H S Villanueva , Andrade J S Cabezas , Martin R Caceres , Garcia J M Miralles , Hernandez J J Corrales

Introduction: Gastroenteropancreatic neuroendocrine tumors have a highly variable presentation, which can range from benign neoplastic growths to rapidly aggressive malignancies. Neuroendocrine carcinomas of the digestive system are relatively rare. The incidence of GEP NEC in Spain is estimated to be 2.5 – five cases per 100 000 inhabitants.Case: We describe the case of a 67-year-old man, previously diagnosed with hypertension and dyslipidemia. He ...

ea0026p327 | Obesity | ECE2011

Inflammatory T-lymphocyte proliferation in morbid obesity

van der Weerd K , Dik W A , Schrijver B , Schweitzer D H , Langerak A W , Kiewiet R M , van Aken M O , van Dongen J J M , van der Lelij A J , Staal F J T , van Hagen P M

Obesity is one of the leading causes of preventable death in the Western world, and its prevalence is dramatically increasing. Although obesity is primarily a metabolic disease, immunological aberrations also significantly contribute to obesity-related morbidity. The well-established state of chronic low-grade inflammation is considered to be crucial in the development of complications such as diabetes and atherosclerosis. Moreover, obesity is associated with increased suscept...